 |
Cell skeleton may hold key to overcoming drug resistance in cancer
October 04, 2007Researchers have uncovered a new way in which a cell protein protects cancer cells from a wide range of chemotherapeutic drugs, identifying a possible target for improving treatment outcomes for patients.
A team of scientists at Children's Cancer Institute Australia for Medical Research (CCIA), led by Associate Professor Maria Kavallaris, discovered that the bIII-tubulin component of the cell's cytoskeleton could play an important role in resistance to a wide range of drugs used to treat lung, ovarian and breast cancers.
Advanced non-small cell lung carcinomas (NSCLC) account for more than 80 per cent of lung cancer cases. More than one million people are diagnosed with lung cancer every year, the most common cancer in the world and the leading cause of cancer deaths. Chemotherapy remains the most effective treatment option, involving a diverse range of drugs, often used in combination. However, the emergence of drug-resistant tumours in NSCLC means chemotherapy no longer holds the promise of a good outcome for many patients.
Increased expression of bIII-tubulin has been linked to drug resistance in NSCLC, ovarian and breast cancers. In the latest Cancer Research publication, Associate Professor Kavallaris and her team showed that blocking the expression of the bIII-tubulin gene in NSCLC cells led to an increase in their sensitivity to a range of chemotherapeutic drugs.
"Our results strongly suggest that the bIII-tubulin component is responsible for protecting NSCLC cells from the action of key chemotherapeutic drugs," said Associate Professor Kavallaris.
"This is the first scientific evidence for the broader implications of abnormal expression of this protein.
"We now have new insight into a mechanism of drug resistance in NSCLC which has not previously been reported. This has important implications for improving the targeting and treatment of a number of cancers which are resistant to current chemotherapeutic drugs," said Associate Professor Kavallaris.
Research Australia
Related Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles
More Effective Immunotherapy for Melanoma Hinges on Blocking Suppressive Factors, Moffitt Cancer Center Researchers Say
Researchers at the Moffitt Cancer Center have found that delayed tumor growth and enhanced survival of mice bearing melanoma were possible by blocking the reconstitution of myeloid-derived suppressor cells and Tregs (suppressors of anti-tumor activity) after total body irradiation had eliminated them.
CWRU School of Medicine researchers discover gene that permanently stops cancer cell proliferation
Researchers at Case Western Reserve University School of Medicine have discovered a mutant form of the gene, Chk1, that when expressed in cancer cells, permanently stopped their proliferation and caused cell death without the addition of any chemotherapeutic drugs.
Regulation by proteins outside cancer cells points to potential new drug target
Protein interactions outside breast cancer cells can send signals to the cancer cells to permanently stop proliferating, a new study showed in the School of Medicine at The University of Texas Health Science Center San Antonio.
Nanoparticles engineered at Notre Dame promise to improve blood cancer treatment
Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow.
Experimental agent may help older people with chronic leukemia
The experimental drug ibrutinib (PCI-32765) shows great promise for the treatment of elderly patients with chronic lymphocytic leukemia (CLL), according to interim findings from a clinical trial.
Nanoparticles may enhance cancer therapy
A mixture of current drugs and carbon nanoparticles shows potential to enhance treatment for head-and-neck cancers, especially when combined with radiation therapy, according to new research by Rice University and the University of Texas MD Anderson Cancer Center.
Low dose naltrexone (LDN): Harnessing the body's own chemistry to treat human ovarian cancer
Researchers at The Pennsylvania State University College of Medicine, Hershey, Pennsylvania have discovered that a low dose of the opioid antagonist naltrexone (LDN) has an extraordinarily potent antitumor effect on human ovarian cancer in tissue culture and xenografts established in nude mice.
Gene change identifies brain cancer patients that respond better to treatment
New research proves that a change in a particular gene can identify which patients with a specific kind of brain cancer will respond better to treatment.
Rituximab And Fludarabine Produce Long-Term Remissions in CLL
New research shows that a less-toxic combination of a targeted immune-based drug and a chemotherapy drug can produce long-term remissions in some chronic lymphocytic leukemia patients.
Cancer Drug Linked to Quantum Dots Increases Drug Uptake, Reduces Inflammatory Response, UB Researchers Show
Researchers at the University at Buffalo have developed a novel technology using quantum dots that is expected to have major implications for research and treatment of tuberculosis, as well as other inflammatory lung diseases.
More Chemotherapeutic Drug Current Events and Chemotherapeutic Drug News Articles
 |
Basic and Clinical Pharmacology 12/E (LANGE Basic Science) by Bertram Katzung (Author), Susan Masters (Author), Anthony Trevor (Author) The most up-to-date, comprehensive, and authoritative pharmacology text in health medicine Enhanced by more than three hundred illustrations -- many in full color Organized to reflect the syllabi in many pharmacology courses and in integrated curricula, Basic & Clinical Pharmacology, 12e covers the important concepts students need to know about the science of pharmacology and its application to clinical practice. Selection of the subject matter and order of its presentation are based on the authors’ many years experience in teaching this material to thousands of medical, pharmacy, dental, podiatry, nursing, and other health science students. To be as clinically relevant as possible, the book includes sections that specifically address the clinical choice and use of drugs in patients... |
 |
First Aid for the USMLE Step 1 2013 (First Aid USMLE) by Tao Le (Author), Vikas Bhushan (Author) THE WORLD'S BESTSELLING MEDICAL REVIEW BOOK--WITH MORE THAN 1,200 FREQUENTLY TESTED FACTS AND MNEMONICS Conveniently organized by organ system and general principles 125+ color clinical photographs integrated throughout the text Hundreds of full-color illustrations clarify essential concepts and improve retention Rapid-review section for last-minute cramming Detailed test-taking strategies to help you maximize your study time Hundreds of student-recommended USMLE Step 1 review resources Advice from students who aced the 2012 exam 1200+ frequently tested facts and mnemonics Hundreds of high-yield color images and diagrams throughout Student ratings of more than 300 review products |
 |
Burger's Medicinal Chemistry and Drug Discovery, Chemotherapeutic Agents (Burger's Medicinal Chemistry & Drug Discovery) (Volume 5) by Donald J. Abraham (Editor) This is Volume 5: Chemotherapeutic Agents, of Burger's Medicinal Chemistry and Drug Discovery, 6th Edition. This new volume contains critical new chapters on Molecular Biology of Cancer, Synthetic Anti-angiogenic Agents and Selective Toxicities. To purchase the entire 6 volume set, please refer to ISBN 0-471-37032-0. For a complete list of articles and contributors as well as FREE sample chapters from this new 6th Edition please visit: www.mrw.interscience.wiley.com/bmcdd |
 |
Prioritization, Delegation, and Assignment: Practice Exercises for the NCLEX Examination, 2e by Linda LaCharity (Author), Candice K. Kumagai (Author), Barbara Bartz (Author) Prioritization, Delegation, and Assignment: Practice Exercises for the NCLEX® Examination is the only review book on the market with a focus on prioritization and management of care-just like the current NCLEX Examination itself! The workbook's unique approach establishes your foundational knowledge and then provides exercises of increasing difficulty to help you build confidence in your prioritization, delegation, and patient assignment skills. It offers unique preparation for the NCLEX Examination and effectively equips you to practice in today's fast-paced healthcare environment.The only workbook available that provides in-depth practice with prioritization, delegation, and assignment questions similar to those you'll see on the NCLEX Examination, including questions in alternate item... |
 |
The Gerson Therapy: The Proven Nutritional Program for Cancer and Other Illnesses by Charlotte Gerson (Author), Morton Walker D.P.M. (Author) Cancer. Hepatitis. Migraines. Arthritis. Heart Disease. Emphysema. For years, the medical establishment has called these chronic or life- threatening diseases "incurable." But now, The Gerson Therapy offers hope for those seeking relief from hundreds of different diseases. Juice your way to wellness. One of the first alternative cancer therapies, The Gerson Therapy has successfully treated thousands of patients for over 60 years. Now, in this authoritative revised and updated edition, alternative medicine therapist Charlotte Gerson and medical journalist Morton Walker reveal even more on the powerful healing effects of organic fruits and vegetables. Not only can juicing reverse the effects of many degenerative illnesses-it can save lives. The Gerson Therapy shows you: ... |
 |
Step-Up to Medicine (Step-Up Series) by Steven S. Agabegi (Author), Elizabeth Agabegi (Author) Step-Up to Medicine is your lifeline for the clinical years of medical school. This book was originally written by third-year medical students searching for the perfect review book—not finding it on the market, they wrote it themselves! Now in its third edition, Step-Up to Medicine boils down the full scope of tested pathology in a single ingenious tool. Each element is tailored for immediate content absorption, and an all-new, full-color interior differentiate elements for even faster, more efficient review. And, Step-Up to Medicine, third edition provides two types of self-assessment—the kinds of questions you will ask yourself as a clinician plus USMLE-style practice questions. This review book gives you just the Step-Up to the medicine clerkship, accompanying shelf exams, and... |
 |
Katzung & Trevor's Pharmacology Examination and Board Review,10th Edition (Lange Medical Books) by Anthony Trevor (Author), Bertram Katzung (Author), Susan Masters (Author), Marieke Knuidering-Hall (Author) MORE THAN 1000 Q&As PREPARE YOU FOR MEDICAL PHARMACOLOGY COURSE EXAMS AND BOARD EXAMINATIONS From the authors of pharmacology's #1 textbook, Katzung & Trevor's Basic & Clinical Pharmacology, Twelfth Edition, this review delivers a clear, concise review of fundamental concepts backed by more than 1,000 review questions and answers. The chapter-based approach facilitates use with course notes or larger texts. Outstanding learning aids include: Short discussion of the major concepts that underlie basic principles or specific drug groups Explanatory figures and tables Review questions followed by answers and explanations Drug trees in drug-oriented chapters that visually organize drug groups A list of high-yield terms and definitions you need to know Skill Keeper Questions that prompt you to... |
 |
2013 Oncology Nursing Drug Handbook by Gail M. Wilkes (Author), Margaret Barton-Burke (Author) Written especially for nurses caring for patients with cancer, the 2013 Oncology Nursing Drug Handbook uniquely expresses drug therapy in terms of the nursing process: nursing diagnoses, etiologies of toxicities, and key points for nursing assessment, intervention, and evaluation. Updated annually, this essential reference provides valuable information on effective symptom management, patient education, and chemotherapy administration. Completely revised and updated, the 2013 Oncology Nursing Drug Handbook includes: * New drug entries and revisions * Specific drugs described in terms of their mechanism of action, metabolism, drug interactions, laboratory effects/interference, and special considerations * The most important and common drug side effects * Greater discussion of fundamentals... |
 |
The Emperor of All Maladies: A Biography of Cancer by Siddhartha Mukherjee (Author) The Emperor of All Maladies is a magnificent, profoundly humane “biography” of cancer—from its first documented appearances thousands of years ago through the epic battles in the twentieth century to cure, control, and conquer it to a radical new understanding of its essence. Physician, researcher, and award-winning science writer, Siddhartha Mukherjee examines cancer with a cellular biologist’s precision, a historian’s perspective, and a biographer’s passion. The result is an astonishingly lucid and eloquent chronicle of a disease humans have lived with—and perished from—for more than five thousand years. The story of cancer is a story of human ingenuity, resilience, and perseverance, but also of hubris, paternalism, and misperception. Mukherjee recounts centuries of... |
 |
Understanding Pathophysiology, 5e (Huether, Understanding Pathophysiology) by Sue E. Huether RN PhD (Author), Kathryn L. McCance RN PhD (Author) Learn the essential concepts of pathophysiology and stay up to date on treatments, manifestations, and mechanisms of disease with Understanding Pathophysiology, 5th Edition. Filled with vibrant illustrations and complemented by online resources that bring pathophysiology concepts to life, this easy-to-read text delivers the latest, most accurate information on the disease process across the lifespan, giving you the fundamental knowledge you need to move forward in your nursing education. Consistent presentation helps you better distinguish pathophysiology, clinical manifestations, and evaluation and treatment for each disease.More than 1,000 high-quality illustrations vividly depict clinical manifestations and cellular mechanisms underlying diseases.Lifespan coverage details age-specific... |
| © 2013 BrightSurf.com |